Alnylam Pharmaceuticals (ALNY) PT Raised to $154 at Cowen; Named Best 2020 Idea
Tweet Send to a Friend
Cowen analyst Ritu Baral raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $154.00 (from $120.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
